Wall Street brokerages expect Aetna Inc. (NYSE:AET) to report $2.08 earnings per share for the current quarter, Zacks reports. Six analysts have issued estimates for Aetna’s earnings, with estimates ranging from $1.87 to $2.18. Aetna reported earnings per share of $2.07 during the same quarter last year, which would indicate a positive year over year growth rate of 0.5%. The company is scheduled to report its next quarterly earnings report on Thursday, October 26th.

According to Zacks, analysts expect that Aetna will report full year earnings of $9.54 per share for the current financial year, with EPS estimates ranging from $9.49 to $9.63. For the next year, analysts anticipate that the business will report earnings of $10.13 per share, with EPS estimates ranging from $10.03 to $10.35. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Aetna.

Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter last year, the company posted $2.21 earnings per share. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year.

Several research firms have weighed in on AET. UBS AG reaffirmed a “buy” rating and set a $160.00 price target (up previously from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Argus reaffirmed a “buy” rating and set a $165.00 price target (up previously from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. Credit Suisse Group reaffirmed a “buy” rating and set a $155.00 price target on shares of Aetna in a research report on Wednesday, May 17th. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Finally, BidaskClub lowered Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Seven equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $157.99.

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its position in shares of Aetna by 3,374.9% during the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after acquiring an additional 29,828,390 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Aetna by 3.8% during the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after acquiring an additional 838,578 shares during the last quarter. Capital World Investors increased its position in shares of Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after acquiring an additional 1,688,767 shares during the last quarter. FMR LLC increased its position in shares of Aetna by 73.8% during the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after acquiring an additional 5,833,567 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Aetna by 3.9% during the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock valued at $558,540,000 after acquiring an additional 165,278 shares during the last quarter. 89.58% of the stock is owned by institutional investors.

WARNING: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/10/zacks-brokerages-expect-aetna-inc-aet-to-announce-2-08-earnings-per-share.html.

Shares of Aetna (NYSE:AET) traded up 1.61% during trading on Friday, reaching $162.83. The company’s stock had a trading volume of 2,081,127 shares. The company has a market cap of $54.01 billion, a PE ratio of 36.10 and a beta of 0.53. The stock’s 50 day moving average price is $156.27 and its 200 day moving average price is $143.85. Aetna has a 52 week low of $104.59 and a 52 week high of $163.16.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Get a free copy of the Zacks research report on Aetna (AET)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.